IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,241,062 | +54.7% | 530,452 | +61.8% | 0.28% | +68.5% |
| Q4 2022 | $2,095,447 | -33.3% | 327,926 | 0.0% | 0.17% | -36.8% |
| Q3 2022 | $3,142,000 | -30.9% | 327,926 | -20.4% | 0.27% | -30.9% |
| Q2 2022 | $4,549,000 | -33.7% | 412,088 | -0.0% | 0.38% | -28.4% |
| Q1 2022 | $6,864,000 | -62.1% | 412,262 | -56.6% | 0.54% | -53.5% |
| Q4 2021 | $18,133,000 | -15.4% | 949,884 | +9.2% | 1.16% | -13.1% |
| Q3 2021 | $21,443,000 | +4.5% | 869,540 | +10.3% | 1.33% | +28.0% |
| Q2 2021 | $20,518,000 | +167.9% | 788,562 | +226.0% | 1.04% | +104.9% |
| Q1 2021 | $7,658,000 | – | 241,896 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |